Published in J Diabetes Sci Technol on November 01, 2011
Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol (2014) 2.19
A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease. Diabetes Care (2012) 0.94
Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions. Diabetes Care (2016) 0.87
Emerging trends in optical sensing of glycemic markers for diabetes monitoring. Trends Analyt Chem (2015) 0.86
Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference. Diabetes Care (2016) 0.81
Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes. BMJ Open Diabetes Res Care (2016) 0.80
Development of an HbA1c-based conversion equation for estimating glycated albumin in a Korean population with a wide range of glucose intolerance. PLoS One (2014) 0.79
Usefulness of glycated albumin assay for diabetes monitoring. J Diabetes Sci Technol (2011) 0.78
Diagnostic Utility of Serum Glycated Albumin for Diabetes Mellitus and Its Correlation With Hyperlipidemia. Ann Lab Med (2016) 0.75
Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus. J Diabetes Investig (2015) 0.75
GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS. Endocr Pract (2015) 0.75
Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured? Clin Chem (2016) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem (2001) 3.63
Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care (1995) 3.06
Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med (2011) 2.19
Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med (2004) 2.01
Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem (1986) 1.90
Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. J Biol Chem (1979) 1.89
The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem (1983) 1.58
An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta (2002) 1.55
Clinical impact of glycated albumin as another glycemic control marker. Endocr J (2010) 1.53
Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J (2006) 1.41
Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta (2004) 1.37
A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care (2008) 1.35
Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci U S A (1979) 1.32
Glycosylated hemoglobins (GHb): an index of red cell survival. Blood (1982) 1.32
A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol (2008) 1.17
Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem (2010) 1.08
Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus. Mol Diagn Ther (2010) 0.98
Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta (2007) 0.97
Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography. Clin Chem (1984) 0.96
Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem (2007) 0.96
Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? J Diabet Complications (1989) 0.95
Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA). Clin Chem (1998) 0.86
Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. J Immunol Methods (1989) 0.85
High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin. J Chromatogr (1992) 0.81
Radioimmunoassay of glycosylated albumin with monoclonal antibody to glucitol-lysine. Clin Chim Acta (1987) 0.80
Reduction of reaction differences between human mercaptalbumin and human nonmercaptalbumin measured by the bromcresol purple method. Clin Chim Acta (1999) 0.80
Precise measurement of glycated serum albumin by column affinity chromatography and immunoturbidimetry. Clin Chim Acta (1986) 0.79
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int (2012) 3.46
Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol (2008) 3.16
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int (2013) 3.09
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet (2011) 2.54
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet (2010) 2.51
Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes (2008) 2.41
Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrol Dial Transplant (2011) 2.26
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol (2011) 2.19
A genome scan for diabetic nephropathy in African Americans. Kidney Int (2004) 2.00
A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int (2010) 1.98
Pericardial and visceral adipose tissues measured volumetrically with computed tomography are highly associated in type 2 diabetic families. Invest Radiol (2005) 1.98
Familial clustering of chronic kidney disease. Semin Dial (2007) 1.95
Heritability of body composition measured by DXA in the diabetes heart study. Obes Res (2005) 1.94
The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications (2005) 1.87
Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes (2007) 1.86
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol (2003) 1.85
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79
Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke (2002) 1.78
An update on pruritus associated with CKD. Am J Kidney Dis (2007) 1.75
The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol (2010) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Genetic factors in end-stage renal disease. Kidney Int Suppl (2005) 1.71
Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud (2010) 1.69
Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol (2008) 1.68
Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61
Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study. Nephrol Dial Transplant (2006) 1.59
Informed conditioning on clinical covariates increases power in case-control association studies. PLoS Genet (2012) 1.57
Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes (2008) 1.53
Race-specific relationships between coronary and carotid artery calcification and carotid intimal medial thickness. Stroke (2004) 1.53
Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.52
Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. Am J Nephrol (2011) 1.52
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis (2004) 1.47
Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens (2013) 1.47
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int (2010) 1.45
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43
Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud (2012) 1.42
Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study. Diabetes Care (2011) 1.41
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis (2011) 1.41
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes (2006) 1.39
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet (2010) 1.38
Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet (2008) 1.36
The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet (2011) 1.35
Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes (2010) 1.30
Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci (2008) 1.29
A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes (2004) 1.26
Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes (2008) 1.22
Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet (2012) 1.22
Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant (2013) 1.21
Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br J Nutr (2011) 1.20
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum (2011) 1.19
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis (2011) 1.19
Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int (2005) 1.18
Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone (2007) 1.18
Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care (2012) 1.17
Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study. Diabetes Care (2009) 1.15
Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet (2013) 1.14
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet (2012) 1.14
A comparison of risk factors for calcified atherosclerotic plaque in the coronary, carotid, and abdominal aortic arteries: the diabetes heart study. Am J Epidemiol (2007) 1.13
Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care (2012) 1.12
Transferability and fine mapping of type 2 diabetes loci in African Americans: the Candidate Gene Association Resource Plus Study. Diabetes (2012) 1.12
Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol (2010) 1.12
The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. Hum Genet (2009) 1.11
Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clin J Am Soc Nephrol (2011) 1.08
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study. Circulation (2013) 1.07
Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol (2011) 1.07
Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin J Am Soc Nephrol (2010) 1.07
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis (2012) 1.07
Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res (2011) 1.06
Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol (2010) 1.05
Reappraisal of the impact of race on survival in patients on dialysis. Am J Kidney Dis (2010) 1.04
Essential hypertension and risk of nephropathy: a reappraisal. Curr Opin Nephrol Hypertens (2010) 1.04
Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis. Am J Nephrol (2010) 1.04
Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report. Am J Kidney Dis (2010) 1.04
The relationship between albuminuria and hormone therapy in postmenopausal women. Am J Kidney Dis (2005) 1.04
End-stage renal failure in African Americans: insights in kidney disease susceptibility. Nephrol Dial Transplant (2002) 1.03
Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diab Vasc Dis Res (2008) 1.03
Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes (2004) 1.02
Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study. Cardiovasc Diabetol (2013) 1.02
The impact of pedigree structure on heritability estimates for pulse pressure in three studies. Hum Hered (2005) 1.02
Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study. J Clin Endocrinol Metab (2010) 1.02
Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA. Hum Genet (2010) 1.01
APOL1 and progression of nondiabetic nephropathy. J Am Soc Nephrol (2013) 1.01
A comparison of type 2 diabetes risk allele load between African Americans and European Americans. Hum Genet (2014) 1.01
Genome-wide association of BMI in African Americans. Obesity (Silver Spring) (2011) 1.01
Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans. Genomics (2010) 1.00
Novel findings and future directions on the genetics of hypertension. Curr Opin Nephrol Hypertens (2012) 1.00
Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J (2006) 1.00
Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis (2008) 0.99
MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet (2013) 0.99
The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). Am Heart J (2005) 0.99